Stereotactic body radiotherapy for lung cancer

被引：0
|
作者：
Nagata, Y [1 ]
Hiraoka, M [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Therapeut Radiol & Oncol, Kyoto, Japan
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [41] Stereotactic radiotherapy for primary lung cancer
    Phillips, I.
    Flint, R.
    Hin, B.
    Ezhil, V.
    [J]. CLINICAL ONCOLOGY, 2017, 29 : S10 - S11
  • [42] Outcomes of stereotactic body radiotherapy for intrapulmonary recurrence after lung cancer surgery
    Nakamura, D.
    Yamazaki, T.
    Yasui, K.
    Egawa, A.
    Hayashi, N.
    Uetani, M.
    Ashizawa, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S635 - S636
  • [43] Stereotactic body radiotherapy for early stage lung cancer: History and updated role
    Ricardi, Umberto
    Badellino, Serena
    Filippi, Andrea Riccardo
    [J]. LUNG CANCER, 2015, 90 (03) : 388 - 396
  • [44] Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
    Luca Nicosia
    Francesco Cuccia
    Rosario Mazzola
    Francesco Ricchetti
    Vanessa Figlia
    Niccolò Giaj-Levra
    Michele Rigo
    Davide Tomasini
    Nadia Pasinetti
    Stefanie Corradini
    Ruggero Ruggieri
    Filippo Alongi
    [J]. Strahlentherapie und Onkologie, 2020, 196 : 813 - 820
  • [45] Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
    Nicosia, Luca
    Cuccia, Francesco
    Mazzola, Rosario
    Ricchetti, Francesco
    Figlia, Vanessa
    Giaj-Levra, Niccolo
    Rigo, Michele
    Tomasini, Davide
    Pasinetti, Nadia
    Corradini, Stefanie
    Ruggieri, Ruggero
    Alongi, Filippo
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 813 - 820
  • [46] The clinical outcomes of breast cancer lung metastasis treated with stereotactic body radiotherapy
    Guler, O. C.
    Sari, S. Yuce
    Gultekin, M.
    Yildiz, F.
    Onal, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1040 - S1041
  • [47] Time to local failure and prognosis in lung cancer treated with stereotactic body radiotherapy
    Hamamoto, Y.
    Kanzaki, H.
    Nagasaki, K.
    Makita, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1077 - S1077
  • [48] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    [J]. LUNG CANCER, 2013, 79 : S58 - S59
  • [49] Pulmonary Function Change after Stereotactic Body Radiotherapy for Primary Lung Cancer
    Ueki, N.
    Matsuo, Y.
    Shibuya, K.
    Nakamura, A.
    Sakanaka, K.
    Narabayashi, M.
    Mizowaki, T.
    Hiraoka, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S617 - S617
  • [50] Outcomes after stereotactic ablative body radiotherapy for stage 1 lung cancer
    Phillips, I.
    Chandy, E.
    Yusof, H.
    Lodge, D.
    Bishop, L.
    Mahendran, P.
    Halling-Brown, M.
    Saxby, H.
    Ezhil, V.
    [J]. LUNG CANCER, 2019, 127 : S72 - S73
12345